Eyelid sebaceous carcinoma: Validation of the 8th edition of the American Joint Committee on cancer T staging system and the prognostic factors for local recurrence, nodal metastasis, and survival

Upon completion of this activity, participants will be able to: 1. Describe clinicopathological features of eyelid SGC in the ethnic Chinese population in Taiwan, according to a retrospective study 2. Determine prognostic factors for eyelid SGC in the ethnic Chinese population in Taiwan, according to a retrospective study 3. Compare the 7th and 8th editions of the AJCC staging system for diagnostic performance regarding the outcomes of local recurrence, regional lymph node metastasis, and tumor-related death, according to a retrospective study Describe clinicopathological features of eyelid SGC in the ethnic Chinese population in Taiwan, according to a retrospective study Determine prognostic factors for eyelid SGC in the ethnic Chinese population in Taiwan, according to a retrospective study Compare the 7th and 8th editions of the AJCC staging system for diagnostic performance regarding the outcomes of local recurrence, regional lymph node metastasis, and tumor-related death, according to a retrospective study In support of improving patient care, this activity has been planned and implemented by Medscape, LLC and Springer Nature. Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Medscape, LLC designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 1.0 Release date: 31 May 2019 Expiration date: 31 May 2020 Post-test link: https://medscape.org/eye/posttest912117 S.S. has disclosed the following relevant financial relationships: Served as an advisor or consultant for: Allergan, Inc.; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Heidelberg Pharma GmbH; Novartis Pharmaceuticals Corporation; Optos; Roche. Served as a speaker or a member of a speakers bureau for: Allergan, Inc.; Bayer AG; Novartis Pharmaceuticals Corporation; Optos. Received grants for clinical research from: Allergan, Inc.; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; Optos. Y.H., C.-Y.Y., Y.-H.W., L.-W.C., S.-L.L. have disclosed no relevant financial relationships. Laurie Barclay has disclosed no relevant financial relationships.